Invokana (canagliflozin) is a prescription drug that’s used for conditions related to type 2 diabetes. It can cause side effects that range from mild to serious. Examples include weight loss and ...

Your doctor may prescribe Invokana for these uses only in certain situations. To learn more about how Invokana is used, see “What is Invokana used for?” below. Invokana contains the active drug ...

The top 40 pharma companies spent almost a quarter-billion on TV advertising ($231 million) in September, airing ads more than 91,000 times. Of those spots, more than 20% (18,753) ran in primetime.

TITUSVILLE, N.J., Oct. 30, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved INVOKANA ® ...

Janssen announced data from three real-world analyses for Invokana (canagliflozin) in adults with type 2 diabetes. The first was a retrospective observational study (n=16,613) of adults with type 2 ...

Forbes contributors publish independent expert analyses and insights. I report the latest in health, nutrition, wellness and healthy travel. A new treatment option will soon be available to people ...

INVOKANA (canagliflozin) 100mg and 300mg tablets The FDA has approved Janssen Pharmaceuticals' Invokana tablets for the treatment of type 2 diabetes. Invokana belongs to a new class of diabetes drugs ...

Type 2 diabetes is on the rise in the U.S.--and so is TV ad spending for drugs to treat the condition. New medicines, along with increased marketing budgets on older meds, more than doubled diabetes ...

Earlier this week, the FDA gave a jolt to Johnson & Johnson‘s diabetes business when it concluded that J&J must include a label warning that patients using its diabetes drug Invokana are at a higher ...

Sales of the diabetes drug Invokana have spiked to more than $1 billion in the past year. First, a bit of background Invokana, which got Food and Drug Administration approval in 2013, helps diabetes ...